Eli Lilly stock sell-off was 'overrreaction': Analysts
Despite beating on its earnings Thursday, pharma giant Eli Lilly (LLY) suffered a nearly 12% loss in its stock, losing more than $90 billion in market cap in a single day. The move, some analysts say, was an overreaction to the news that GLP-1 competitor …